GIB Capital, in its capacity as financial advisor and bookrunner to the Arab Company for Drug Industries & Medical Appliances (“ACDIMA”), is pleased to announce the successful completion of the sale of ACDIMA’s entire remaining stake in Saudi Pharmaceutical Industries & Medical Appliances Corporation (“SPIMACO”) through an accelerated bookbuilding process.

The transaction involved the sale of 12,588,173 shares, representing approximately 10.49% of SPIMACO’s issued share capital, at a price of SAR 27.90 per share, generating total proceeds of approximately SAR 351.21 million. The sale was executed through negotiated deals on the Saudi Exchange (Tadawul) on 6 September 2026. 

The offering attracted strong demand from both local and international institutional investors and was successfully oversubscribed, reflecting robust investor demand and confidence in the transaction. 

Following completion of the transaction, ACDIMA no longer holds any shares in SPIMACO.

GIB Capital has been providing a range of innovative and customized financial and investment banking products and solutions, including debt capital markets, capital markets advisory, mergers and acquisitions, debt advisory, asset management, and brokerage services.